Traditional serum lung cancer biomarkers, such as carcinoembryonic antigen (CEA), squamous cell carcinoma antigen (SCCA) and neuron-specific enolase (NSE), have been clinically used for years. The gene discussed is CEACAM5; the disease is lung cancer.